Pharmabiz1h
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...
Pharmabiz2h
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries: Malvern, Pennsylvania Thursday, January 16, 2025, 17:00 Hrs [IST] Anno ...
Pharmabiz4h
icotec gets US FDA 510(k) clearance for use of BlackArmor implants to treat de novo spinal infections
FDA clearance for the use of BlackArmor implants in the treatment of de novo spinal infections. icotec is honoured to be the first and only company in the United States with FDA 510(k) clearance for ...
Pharmabiz3h
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia: South San Francisco, California Thursday, January 16, 2025, 16:00 Hrs [IST] Vistagen ...
Pharmabiz2d
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...
Pharmabiz2d
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
Pharmabiz1d
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...
Pharmabiz5h
ACT commits Rs. 8.33 crore to the future of rural healthcare in India with Khushi Baby & Medoplus
ACT commits Rs. 8.33 crore to the future of rural healthcare in India with Khushi Baby & Medoplus: Our Bureau, Bengaluru Thursday, January 16, 2025, 14:15 Hrs [IST] ACT, an Indian ...
Pharmabiz5h
Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours
Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours: New York Thursday, January 16, 2025, 14:00 Hr ...
Pharmabiz5h
Glaukos announces positive clinical updates for its iDose sustained-release procedural pharmaceutical platform
Glaukos announces positive clinical updates for its iDose sustained-release procedural pharmaceutical platform: Aliso Viejo, California Thursday, January 16, 2025, 14:30 Hrs [IST] ...
Pharmabiz1d
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz6d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...